- Home
- Your Messages
-
Smartest Doc
Test your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
We invite you to take the "Diabetes Expert Quiz"
Current Top Players:
1) Dr. Mike Lemay
2) Dr. Barry Vance
3) Dr. Rafael Chiong
>> Live LeaderboardNew! PHYSICIAN REVIEW
Assess your general knowledge at the topic level with your personalized scorecard.
Thousands of multiple-choice questions pinpoint your areas of expertise and prep you for exams.
- Physician Jobs (1168)
- More
- Other Specialty
Endocrinology - Adrenal Glands News & Articles
MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Endocrinology
See All >> Messages include industry-sponsored communications and special communications from MDLinx-
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC -
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage -
Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls -
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools -
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
Articles
Latest Full Text Articles (62) Focus on Diabetes361 Prevalence of adrenal haemorrhage in non-surviving patients with burns Burns, September 27, 2011
362 Challenges in clinical and laboratory diagnosis of androgen insensitivity syndrome: a case report Full Text Journal of Medical Case Reports, September 21, 2011
363 Recognition and management of phaeochromocytoma Anaesthesia & intensive care medicine, September 20, 2011
364 Adrenal Myelolipoma And Membranoproliferative Glomerulonephritis: Case Report Full Text The Internet Journal of Urology, September 16, 2011
365 Complete remission of primary bilateral adrenal lymphoma achieved by Rituximab-CHOP chemotherapy Central European Journal of Medicine, September 15, 2011
366 Outcome of Surgery for Primary Hyperaldosteronism World Journal of Surgery, September 14, 2011
367 Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotypephenotype correlation in a large cohort of patients with congenital adrenal hyperplasia Clinical Endocrinology, September 13, 2011
368 Minimally Invasive Treatment of Metastatic Pheochromocytoma and Paraganglioma: Efficacy and Safety of Radiofrequency Ablation and Cryoablation Therapy Journal of Vascular and Interventional Radiology, September 12, 2011
369 The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas Pituitary, September 12, 2011
370 CT and MR Imaging of the Adrenal Glands in Cortisol-secreting Tumors Anticancer Research, September 12, 2011
371 Changes in Steroid Concentrations with the Timing of ACTH Stimulation Testing in Normal Subjects Endocrine Practice, September 9, 2011
372 Hormonal and metabolic response to trauma Anaesthesia & intensive care medicine, September 7, 2011
373 Lung Cancer Metastasis to an Adrenal Myelolipoma Detected by PET/CT Clinical Nuclear Medicine , September 7, 2011
374 Effectiveness of a three-dimensional dual gradient echo two-point Dixon technique for the characterization of adrenal lesions at 3 Tesla European Radiology, September 1, 2011
375 Transperitoneal Laparoscopic Adrenalectomy for Adrenal Metastasis Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, August 29, 2011
376 Free Cortisol and Accuracy of Total Cortisol Measurements in the Diagnosis of Adrenal Insufficiency in Brain-dead Patients Anesthesiology, August 26, 2011
377 Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness Full Text Intensive Care Medicine, August 26, 2011
378 Laparoscopic Retroperitoneal Adrenalectomy Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, August 26, 2011
379 Is Adrenal Ovarian Thecal Metaplasia a Misnomer? Report of Three Cases of Radial Scar-Like Spindle Cell Myofibroblastic Nodule of the Adrenal Gland Endocrine Pathology, August 25, 2011
380 Characterization of Adrenal Lesions With 1.5-T MRI: Preliminary Observations on Comparison of Three In-Phase and Out-of-Phase Gradient-Echo Techniques American Journal of Roentgenology, August 24, 2011
Clinical Pearls in Endocrinology
- Pioglitazone can reduce the risk of conversion of impaired glucose tolerance to type 2 diabetes mellitus by 72%, but it was also associated with significant weight gain and edema
- The most commonly reported adverse event associated with Janumet in the treatment of type 2 diabetes is diarrhea, followed by upper respiratory tract infection and headache
- Maturity-onset diabetes of the young (MODY)3 can be treated with sulfonylureas with excellent results for decades
Highlights in Endocrinology
Regulatory protein identified in T1DM
As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.
Read the article summaryStatins increase risk of DM in postmenopausal women
As reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up
Read the article summaryDetermining the basal insulin dosage in T2DM
Anthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.
Read the article summaryMost Popular Endocrinology Articles
Last month's top read Top Articles of 2012Indexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more
Other Topics in Endocrinology
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close